Aliases & Classifications for Stomatitis

Aliases & Descriptions for Stomatitis:

Name: Stomatitis 12 52 42 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:9637
ICD10 33 K12.1
MeSH 42 D013280
NCIt 47 C26887
UMLS 69 C0038362

Summaries for Stomatitis

MalaCards based summary : Stomatitis is related to hepatitis c virus and aphthous stomatitis, and has symptoms including enanthema, oral manifestations and oral pain. An important gene associated with Stomatitis is LDLR (Low Density Lipoprotein Receptor), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Morphine and Ephedrine have been mentioned in the context of this disorder. Affiliated tissues include t cells, testes and neutrophil, and related phenotypes are Decreased cell number and hematopoietic system

Wikipedia : 71 Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the... more...

Related Diseases for Stomatitis

Diseases related to Stomatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 165)
id Related Disease Score Top Affiliating Genes
1 hepatitis c virus 29.6 DDX58 IFITM2 IFITM3 RSAD2
2 aphthous stomatitis 12.3
3 periodic fever, aphthous stomatitis, pharyngitis and adenitis 12.2
4 denture stomatitis 12.2
5 ulcerative stomatitis 12.1
6 sutton disease 2 11.4
7 noma 11.3
8 hand, foot and mouth disease 11.1
9 glucagonoma 11.1
10 necrotizing ulcerative gingivitis 11.1
11 angular cheilitis 11.1
12 methylmalonic aciduria and homocystinuria, cblf type 10.8
13 pharyngitis 10.4
14 oral candidiasis 10.3
15 cervicitis 10.2
16 tau syndrome 10.2 IL1B MEFV
17 cervical adenitis 10.2
18 mineral metabolism disease 10.2 BST2 DDX58 IL1B
19 wilkes stevenson syndrome 10.1 IL1B MEFV TP63
20 hidradenitis 10.0 CSF2 IL1B MEFV
21 mucositis 10.0
22 exophthalmos 10.0 DDX58 EIF2AK2 IFNA2 IL1B
23 influenza 9.9
24 rheumatoid lung disease 9.9 DDX58 EIF2AK2 IFITM2 IFITM3 NUP98 RSAD2
25 hereditary hemorrhagic telangiectasia 9.9 DDX58 EIF2AK2 IFNA2 LDLR
26 glossitis 9.9
27 eczematous dermatitis of eyelid 9.9 DDX58 EIF2AK2 IFNA2 LDLR
28 lichen planus 9.9
29 encephalitis 9.9
30 hiv-1 9.9
31 diabetes mellitus, insulin-dependent, 22 9.8 ADAR BST2 DDX58 EIF2AK2 HNRNPK LDLR
32 herpes simplex 9.8
33 celiac disease 9.8
34 gingivitis 9.8
35 cheilitis 9.8
36 oral lichen planus 9.8
37 adenocarcinoma 9.8
38 hepatitis 9.8
39 anterior foramen magnum meningioma 9.8 CSF2 IFNA2 IL1B
40 uvulitis 9.8
41 leukemia 9.8
42 periodontitis 9.8
43 measles 9.8
44 pancreatitis 9.8
45 vaccinia 9.7
46 central nervous system disease 9.7
47 pemphigus 9.7
48 neuronitis 9.7
49 prostatitis 9.7
50 nervous system disease 9.7

Graphical network of the top 20 diseases related to Stomatitis:



Diseases related to Stomatitis

Symptoms & Phenotypes for Stomatitis

UMLS symptoms related to Stomatitis:


enanthema, oral manifestations, oral pain, burning mucosal, sore roof of mouth (symptom), oral mucosal blisters

GenomeRNAi Phenotypes related to Stomatitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased cell number GR00303-A 8.92 HNRNPK MTOR NUP98 UBA52

MGI Mouse Phenotypes related to Stomatitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.65 DDX58 EIF2AK2 IL1B LDLR MEFV MTOR
2 immune system MP:0005387 9.4 ADAR CSF2 DDX58 EIF2AK2 IFITM3 IL1B

Drugs & Therapeutics for Stomatitis

Drugs for Stomatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 401)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
2
Ephedrine Approved Phase 4,Phase 1,Phase 2 299-42-3 9294
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
4
Sucralfate Approved Phase 4,Phase 3 54182-58-0
5
Pseudoephedrine Approved Phase 4,Phase 1,Phase 2 90-82-4 7028
6
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 1400-61-9 11953884
7
Ethanol Approved Phase 4,Phase 2,Phase 1 64-17-5 702
8
Zinc Approved Phase 4,Phase 2,Early Phase 1 7440-66-6 32051 23994
9
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3 79217-60-0, 59865-13-3 5284373 6435893
10
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
11
Melphalan Approved Phase 4,Phase 3,Phase 2 148-82-3 4053 460612
12
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
13
Acetaminophen Approved Phase 4,Phase 2,Phase 1 103-90-2 1983
14
Everolimus Approved Phase 4,Phase 3,Phase 2 159351-69-6 6442177
15
Lenograstim Approved Phase 4,Phase 3,Phase 2 135968-09-1
16
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2 55-56-1 9552079 2713
17
Pemetrexed Approved, Investigational Phase 4 150399-23-8, 137281-23-3 446556 60843
18
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2 53123-88-9 5284616 6436030 46835353
19
Hexetidine Approved Phase 4 141-94-6
20
Amifostine Approved, Investigational Phase 4,Phase 2 20537-88-6 2141
21
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
22
leucovorin Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1 58-05-9 54575, 6560146 143
23
Vitamin C Approved, Nutraceutical Phase 4,Phase 2,Phase 3 50-81-7 5785 54670067
24
Docetaxel Approved May 1996, Investigational Phase 4,Phase 2 114977-28-5 148124 9877265
25
Methylene blue Investigational Phase 4,Phase 3 61-73-4
26 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
27
Bilirubin Phase 4,Phase 2 635-65-4 5280352
28 Mitogens Phase 4,Phase 3,Phase 2,Phase 1
29 Adjuvants, Immunologic Phase 4,Phase 2,Phase 3,Phase 1
30 N-Methylaspartate Phase 4,Phase 2
31 Narcotics Phase 4,Phase 3,Phase 2,Phase 1
32 Nasal Decongestants Phase 4,Phase 1,Phase 2
33 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
34 Tetrahydrozoline Phase 4
35 Trace Elements Phase 4,Phase 3,Phase 2,Phase 1
36 Analgesics, Opioid Phase 4,Phase 3,Phase 2,Phase 1
37 Ophthalmic Solutions Phase 4
38 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Vasoconstrictor Agents Phase 4,Phase 1,Phase 2
40 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1
41 Antacids Phase 4,Phase 3,Phase 2
42 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
43 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
44 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
45 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
46 Protective Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
47 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
48 Ionophores Phase 4,Phase 3,Phase 2
49 Respiratory System Agents Phase 4,Phase 2,Phase 1
50 Anti-Ulcer Agents Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 312)
id Name Status NCT ID Phase
1 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
2 A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Completed NCT01283906 Phase 4
3 Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy Completed NCT00357942 Phase 4
4 Effectiveness of Hygiene Solutions on Denture Biofilm Completed NCT02407834 Phase 4
5 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4
6 Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers Completed NCT02642900 Phase 4
7 Hexetidine and Chlorobutanol for Lesions Due to Prostheses Completed NCT01115049 Phase 4
8 A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen Completed NCT01107756 Phase 4
9 Chemotherapy for Patients With Non-Small Cell Lung Cancer Completed NCT00380718 Phase 4
10 Oral Zinc Therapy for the Prevention of Mucositis Completed NCT00449592 Phase 4
11 Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Completed NCT00895583 Phase 4
12 Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye Completed NCT01488396 Phase 4
13 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Recruiting NCT01876407 Phase 4
14 Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer Recruiting NCT01707641 Phase 4
15 A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients Recruiting NCT02948699 Phase 4
16 Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older Recruiting NCT02514174 Phase 4
17 G-CSF in the Treatment of Toxic Epidermal Necrolysis Recruiting NCT02739295 Phase 4
18 Oral Hygiene Regimen in Patients on HCT Enrolling by invitation NCT02662374 Phase 4
19 Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Suspended NCT01288625 Phase 4
20 Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) Withdrawn NCT02695290 Phase 4
21 The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients Unknown status NCT01099891 Phase 3
22 Low-energy Laser Therapy for Prevention of Oral Mucositis in Children Unknown status NCT01007617 Phase 2, Phase 3
23 Lactobacillus Brevis CD2 Preventing Oral Mucositis Unknown status NCT02085694 Phase 2, Phase 3
24 Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer Unknown status NCT00022373 Phase 3
25 Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? Unknown status NCT02020928 Phase 3
26 Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation Unknown status NCT02313792 Phase 3
27 Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults Unknown status NCT02173756 Phase 3
28 The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus Unknown status NCT01083420 Phase 3
29 Traumeel for Post-Tonsillectomy Pain Unknown status NCT00410332 Phase 3
30 COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma Unknown status NCT00603759 Phase 3
31 Prevention of Recurrent Aphthous Stomatitis Using Vitamins Completed NCT00527306 Phase 3
32 Laser for Oral Mucositis in Pediatric Onco-hematology Completed NCT02762019 Phase 3
33 Low-level Laser Therapy on Inflammatory Mediators During Chemotherapy-induced Oral Mucositis Completed NCT02050373 Phase 3
34 Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx Completed NCT00051441 Phase 3
35 Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis Completed NCT02303197 Phase 3
36 Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients Completed NCT01439724 Phase 3
37 Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy Completed NCT02555501 Phase 3
38 Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Completed NCT00101582 Phase 3
39 Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy Completed NCT02229539 Phase 3
40 Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) Completed NCT00109031 Phase 3
41 Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer Completed NCT01837446 Phase 2, Phase 3
42 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Completed NCT00131638 Phase 3
43 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer Completed NCT00393822 Phase 2, Phase 3
44 Curcumin for Prevention of Oral Mucositis in Children Chemotherapy Completed NCT00475683 Phase 3
45 Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy Completed NCT00790322 Phase 3
46 Caphosol in Oral Mucositis Due to Targeted Therapy Completed NCT01265810 Phase 3
47 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma Completed NCT00434161 Phase 3
48 Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy Completed NCT00041665 Phase 3
49 Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation Completed NCT00024037 Phase 2, Phase 3
50 Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis Completed NCT00956254 Phase 3

Search NIH Clinical Center for Stomatitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: stomatitis

Genetic Tests for Stomatitis

Anatomical Context for Stomatitis

MalaCards organs/tissues related to Stomatitis:

39
T Cells, Testes, Neutrophil, Colon, Brain, Monocytes, Tongue

Publications for Stomatitis

Articles related to Stomatitis:

(show top 50) (show all 1379)
id Title Authors Year
1
Mechanism of membrane fusion induced by vesicular stomatitis virus G protein. ( 27974607 )
2017
2
Enzymatic antioxidants status in patients with recurrent aphthous stomatitis. ( 28054386 )
2017
3
Antigastric parietal cell and antithyroid autoantibodies in patients with recurrent aphthous stomatitis. ( 27793414 )
2017
4
Investigation of CD40 gene rs4810485 and rs1883832 mutations in patients with recurrent aphthous stomatitis. ( 27875792 )
2017
5
Efficacy and safety of Chinese patent medicines in the treatment ofA recurrent aphthous stomatitis: A systematic review. ( 28062049 )
2017
6
Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain. ( 28077641 )
2017
7
Uremic stomatitis. ( 28062743 )
2017
8
5' -Phospho-RNA acceptor specificity of GDP polyribonucleotidyltransferase of vesicular stomatitis virus in mRNA capping. ( 28053102 )
2017
9
N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells. ( 27626059 )
2016
10
Aphthous stomatitis. ( 27742082 )
2016
11
Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome. ( 27025724 )
2016
12
Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges. ( 27373596 )
2016
13
Association between serotonin transporter gene polymorphism and recurrent aphthous stomatitis. ( 27274339 )
2016
14
Guidelines for the management and treatment of periodic fever syndromes: periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. ( 27267334 )
2016
15
Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses. ( 27076138 )
2016
16
Fabrication and Evaluation of Nanostructured Herbal Oil/Hydroxypropyl-I^-Cyclodextrin/Polyvinylpyrrolidone Mats for Denture Stomatitis Prevention and Treatment. ( 26821915 )
2016
17
Efficacy of alum for treatment of recurrent aphthous stomatitis. ( 27757206 )
2016
18
Repeatable Population Dynamics among Vesicular Stomatitis Virus Lineages Evolved under High Co-infection. ( 27065953 )
2016
19
Comment on "The relationship of recurrent aphthous stomatitis and Helicobacter pylori, cytokine gene polymorphism and cobalamin". ( 26620964 )
2016
20
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) syndrome: analysis of patients from two geographic areas. ( 27059542 )
2016
21
HLA-DRB and HLA-DQB Allele and Haplotype Frequencies in Iranian Patients with Recurrent Aphthous Stomatitis. ( 27921409 )
2016
22
Long-Term Outcome of Classic and Incomplete PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis) Syndrome after Tonsillectomy. ( 27692464 )
2016
23
Total antioxidant status and oxidative stress in recurrent aphthous stomatitis. ( 26625952 )
2016
24
Is colchicine an effective treatment in periodic fever, aphtous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome? ( 27068612 )
2016
25
Candida albicans biofilm heterogeneity does not influence denture stomatitis, but strongly influences denture cleansing capacity. ( 28032543 )
2016
26
Investigation of BehAset's Disease and Recurrent Aphthous Stomatitis Frequency: The Highest Prevalence in Turkey. ( 27606133 )
2016
27
The safety and efficacy of AphtoFixAr mouth ulcer cream in the management of recurrent aphthous stomatitis. ( 26868504 )
2016
28
EVALUATION OF DENTURE-RELATED FACTORS PREDISPOSING TO DENTURE STOMATITIS IN A LEBANESE POPULATION. ( 27999492 )
2016
29
The vesicular stomatitis virus matrix protein inhibits NF-I_B activation in mouse L929 cells. ( 27643886 )
2016
30
Production of virulence factors in Candida strains isolated from patients with denture stomatitis and control individuals. ( 26971635 )
2016
31
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome: a Review of the Pathogenesis. ( 26984802 )
2016
32
Is there a role of food additives in recurrent aphthous stomatitis? A prospective study with patch testing. ( 28035659 )
2016
33
Status of Neutrophils, Lymphocytes and Platelets in Patients with Recurrent Aphthous Stomatitis: A Retrospective Study. ( 28008393 )
2016
34
Effectiveness of Laser Therapy in the Management of Recurrent Aphthous Stomatitis: A Systematic Review. ( 28078164 )
2016
35
Systemic T Cells and Monocyte Characteristics in Patients with Denture Stomatitis. ( 26883670 )
2016
36
Hematinic deficiencies and anemia statuses in recurrent aphthous stomatitis patients with or without atrophic glossitis. ( 27839675 )
2016
37
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome. ( 27251674 )
2016
38
Evidence Regarding the Treatment of Denture Stomatitis. ( 27062660 )
2016
39
Autophagy Gene Activity May Act As a Key Factor for Sensitivity of Tumor Cells to Oncolytic Vesicular Stomatitis Virus. ( 27366311 )
2016
40
Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles. ( 27649230 )
2016
41
Quality of life in patients with recurrent aphthous stomatitis treated with a mucoadhesive patch containing citrus essential oil. ( 27313450 )
2016
42
Recurrent aphthous stomatitis and Helicobacter pylori. ( 26827061 )
2016
43
Transcription Factors Efg1 and Bcr1 Regulate Biofilm Formation and Virulence during Candida albicans-Associated Denture Stomatitis. ( 27453977 )
2016
44
Oncolytic vesicular stomatitis virus expressing interferon-I^ has enhanced therapeutic activity. ( 27119116 )
2016
45
Efficacy and safety of topical herbal medicine treatment on recurrent aphthous stomatitis: a systemic review. ( 26770058 )
2016
46
Clinical phenotype of recurrent aphthous stomatitis and interleukin-1I^ genotype in a Polish cohort of patients. ( 27935125 )
2016
47
A Broad-Spectrum Chemokine-Binding Protein of Bovine Papular Stomatitis Virus Inhibits Neutrophil and Monocyte Infiltration in Inflammatory and Wound Models of Mouse Skin. ( 27936239 )
2016
48
Clinical study on thermography, as modern investigation method for Candida-associated denture stomatitis. ( 27151707 )
2016
49
Ensemble Structure of the Highly Flexible Complex Formed between Vesicular Stomatitis Virus Unassembled Nucleoprotein and its Phosphoprotein Chaperone. ( 27107640 )
2016
50
Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome. ( 27426283 )
2016

Variations for Stomatitis

Expression for Stomatitis

Search GEO for disease gene expression data for Stomatitis.

Pathways for Stomatitis

Pathways related to Stomatitis according to GeneCards Suite gene sharing:

(show all 12)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.84 ADAR BST2 CSF2 DDX58 EIF2AK2 IFI35
2
Show member pathways
13.08 ADAR BST2 CSF2 DDX58 EIF2AK2 IFI35
3
Show member pathways
12.55 ADAR DDX58 EIF2AK2 HNRNPK IFNA2 IL1B
4
Show member pathways
12.52 ADAR DDX58 IFNA2 IL1B UBA52
5 12.04 ADAR EIF2AK2 HNRNPK MTOR
6 11.85 DDX58 EIF2AK2 IFNA2 LDLR
7
Show member pathways
11.85 ADAR BST2 DDX58 EIF2AK2 IFI35 IFITM2
8
Show member pathways
11.77 ADAR BST2 IFI35 IFITM2 IFITM3 IFNA2
9 11.55 CSF2 IFNA2 IL1B
10 11.15 EIF2AK2 IFNA2 IL1B
11
Show member pathways
10.98 ADAR DDX58 EIF2AK2 IFNA2
12 10.79 LDLR MTOR

GO Terms for Stomatitis

Biological processes related to Stomatitis according to GeneCards Suite gene sharing:

(show all 15)
id Name GO ID Score Top Affiliating Genes
1 viral process GO:0016032 9.95 DDX58 EIF2AK2 HNRNPK LDLR NUP98 RSAD2
2 negative regulation of apoptotic process GO:0043066 9.93 ADAR EIF2AK2 HNRNPK TP63 UBA52
3 immune system process GO:0002376 9.92 ADAR DDX58 EIF2AK2 MEFV RSAD2
4 response to virus GO:0009615 9.91 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
5 positive regulation of gene expression GO:0010628 9.89 CSF2 DDX58 IL1B LDLR MTOR
6 defense response to virus GO:0051607 9.76 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
7 negative regulation of viral genome replication GO:0045071 9.73 ADAR BST2 EIF2AK2 IFITM2 IFITM3 RSAD2
8 response to interferon-gamma GO:0034341 9.71 BST2 IFITM2 IFITM3 MEFV
9 negative regulation of viral entry into host cell GO:0046597 9.63 IFITM2 IFITM3 IFNA2
10 response to interferon-beta GO:0035456 9.61 BST2 IFITM2 IFITM3
11 response to biotic stimulus GO:0009607 9.55 IFITM2 IFITM3
12 positive regulation of granulocyte macrophage colony-stimulating factor production GO:0032725 9.51 DDX58 IL1B
13 response to interferon-alpha GO:0035455 9.35 ADAR BST2 EIF2AK2 IFITM2 IFITM3
14 type I interferon signaling pathway GO:0060337 9.17 ADAR BST2 IFI35 IFITM2 IFITM3 IFNA2
15 innate immune response GO:0045087 10.02 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3

Molecular functions related to Stomatitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.55 ADAR AHSA1 BST2 CSF2 DDX58 EIF2AK2
2 protein domain specific binding GO:0019904 9.26 HNRNPK IL1B MTOR TP63

Sources for Stomatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....